Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Esophageal motility disorders, especially EGJOO and type 3 achalasia, occur more frequently among adults aged 75 years and older.

Nausea is a frequent symptom among individuals with functional dyspepsia, affecting mainly those with PDS-EPS overlap.

A large percentage of patients with SSc screened positive for ARFID, reporting significant GI symptom burden and reduced HRQOL.